E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/14/2017 in the Prospect News Canadian Bonds Daily and Prospect News High Yield Daily.

New Issue: Valeant Pharmaceuticals sells $750 million tap of 5½% secured notes due 2025 at par

By Paul A. Harris

Portland, Ore., Nov. 14 – Valeant Pharmaceuticals International, Inc. priced a $750 million add-on to its 5½% senior secured notes due 2025 (Ba3/BB-) at par on Tuesday afternoon, according to market sources.

The reoffer price came on top of price talk and rendered a 5.498% yield to worst and a 5.499% yield to maturity.

At the time price talk circulated the market, early Tuesday morning, the order book was heard to be three-times oversubscribed, according to a bond trader.

Barclays was the left bookrunner. Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co., DNB Markets, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and RBC Capital Markets LLC were the joint bookrunners.

Laval, Quebec-based specialty pharmaceutical company plans to use the proceeds to repay its series F tranche B term loans due 2022.

Issuer:Valeant Pharmaceuticals International, Inc.
Amount:$750 million
Maturity:Nov. 1, 2025
Security description:Add-on to 5½% senior secured notes due Nov. 1, 2025
Left bookrunner:Barclays
Joint bookrunners:Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co., DNB Markets, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, RBC Capital Markets LLC
Coupon:5½%
Price:Par
Yield to worst:5.498%
Yield to maturity:5.499%
First call:Make-whole call at Treasuries plus 50 bps until Nov. 1, 2020, then callable at 102.75
Equity clawback:40% at 105.5 until Nov. 1, 2020
Trade date:Nov. 14
Settlement date:Nov. 21
Ratings:Moody's: Ba3
S&P: BB-
Distribution:Rule 144A and Regulation S for life
Price talk:Par
Marketing:Investor call
Original issue:$1 billion priced at par on Oct. 2, 2017
Fungibility:Add-on notes will become immediately fungible with original notes
Total issue size:$1.75 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.